Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Generalized junctional epidermolysis bullosa non-Herlitz type (GABEB; MONDO:0019307) is an autosomal recessive blistering disorder characterized by skin fragility, widespread atrophic changes, alopecia, and nail dystrophy. Mutations in LAMB3, encoding the β3 chain of laminin-332, account for a subset of GABEB cases, with the remainder predominantly due to COL17A1 defects.
Inheritance is autosomal recessive, with compound heterozygous or homozygous variants in LAMB3 identified in multiple unrelated probands. A Japanese patient carried a splice acceptor mutation c.1977-2A>G and a 94-bp deletion c.2702-29del94 leading to exon 19 skipping and mRNA instability (PMID:10951252). Two siblings with GABEB exhibited characteristic features and carried LAMB3 or COL17A1 mutations demonstrating familial segregation (PMID:9487212). A study of three additional patients from two families revealed LAMB3 missense and premature termination mutations (e.g., c.628G>A (p.Glu210Lys)) causing mRNA decay and aberrant splicing (PMID:9690563).
The variant spectrum includes splice-site (c.1977-2A>G, c.628G>A), missense (c.628G>A (p.Glu210Lys)), frameshift (c.1365_1366del (p.Asn456fs)), and small deletions (c.2702-29del94) in LAMB3. Recurrent hotspots have been noted in lethal H-JEB but are distinct from non-lethal GABEB alleles.
Segregation analysis supports pathogenicity: affected siblings in two families and compound heterozygosity in unrelated individuals confirm recessive transmission with at least one additional affected relative per kindred.
Functional studies demonstrate exon skipping and enhanced mRNA decay in patient cells, consistent with reduced laminin-332 expression. A LamB3 knockout mouse model exhibits subepidermal blistering and hypoplastic hemidesmosomes, mirroring human JEB phenotypes (PMID:9271670).
No significant conflicting reports disputing LAMB3’s role in GABEB have been identified. The collective genetic and experimental data fulfill criteria for a strong gene–disease association.
Key take-home: LAMB3 loss-of-function variants underlie autosomal recessive GABEB, with clear diagnostic utility for genetic testing and potential targets for future therapeutic interventions.
Gene–Disease AssociationStrongCompound heterozygous and homozygous LAMB3 mutations in ≥4 probands across 3 families with segregation and concordant functional data Genetic EvidenceStrongFive pathogenic LAMB3 alleles (splice, missense, frameshift) in four unrelated probands; AR segregation in two families Functional EvidenceModeratePatient cell RT-PCR showed exon skipping and mRNA decay; LamB3 null mouse recapitulates blistering phenotype |